Reduced DNA methylation of FKBP5 in Cushing's syndrome
Por:
Resmini, E, Santos, A, Aulinas, A, Webb, SM, Vives-Gilabert, Y, Cox, O, Wand, G, Lee, RS
Publicada:
1 dic 2016
Resumen:
FKBP5 encodes a co-chaperone of HSP90 protein that regulates intracellular glucocorticoid receptor sensitivity. When it is bound to the glucocorticoid receptor complex, cortisol binds with lower affinity to glucocorticoid receptor. Cushing's syndrome is associated with memory deficits, smaller hippocampal volumes, and wide range of cognitive impairments. We aimed at evaluating blood DNA methylation of FKBP5 and its relationship with memory and hippocampal volumes in Cushing's syndrome patients. Polymorphism rs1360780 in FKBP5 has also been assessed to determine whether genetic variations can also govern CpG methylation. Thirty-two Cushing's syndrome patients and 32 matched controls underwent memory tests, 3-Tesla MRI of the brain, and DNA extraction from total leukocytes. DNA samples were bisulfite treated, PCR amplified, and pyrosequenced to assess a total of 41CpG-dinucleotides in the introns 1, 2, 5, and 7 of FKBP5. Significantly lower intronic FKBP5 DNA methylation in CS patients compared to controls was observed in ten CpG-dinucleotides. DNA methylation at these CpGs correlated with left and right HV (Intron-2-Region-2-CpG-3: LHV, r = 0.73, p = 0.02; RHV, r = 0.58, p = 0.03). Cured and active CS patients showed both lower methylation of intron 2 (92.37, 91.8, and 93.34 %, respectively, p = 0.03 for both) and of intron 7 (77.08, 73.74, and 79.71 %, respectively, p = 0.02 and p < 0.01) than controls. Twenty-two subjects had the CC genotype, 34 had the TC genotype, and eight had the TT genotype. Lower average DNA methylation in intron 7 was observed in the TT subjects compared to CC (72.5vs. 79.5 %, p = 0.02) and to TC (72.5 vs. 79.0 %, p = 0.03). Our data demonstrate, for the first time, a reduction of intronic DNA methylation of FKBP5 in CS patients.
Filiaciones:
Resmini, E:
Hosp Santa Creu & Sant Pau, Endocrinol Med Dept, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Unidad 747,IIB St Pau,ISCIII, Barcelona, Spain
UAB, Barcelona, Spain
Santos, A:
Hosp Santa Creu & Sant Pau, Endocrinol Med Dept, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Unidad 747,IIB St Pau,ISCIII, Barcelona, Spain
UAB, Barcelona, Spain
Aulinas, A:
Hosp Santa Creu & Sant Pau, Endocrinol Med Dept, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Unidad 747,IIB St Pau,ISCIII, Barcelona, Spain
UAB, Barcelona, Spain
Webb, SM:
Hosp Santa Creu & Sant Pau, Endocrinol Med Dept, Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Unidad 747,IIB St Pau,ISCIII, Barcelona, Spain
UAB, Barcelona, Spain
Vives-Gilabert, Y:
INNDACYT, Avd Europa,20,Bajos D, Barcelona, Spain
Cox, O:
Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA
Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
Wand, G:
Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA
Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
Lee, RS:
Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA
Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
Green Accepted
|